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Abstract
Objectives: Quality of life, mental wellbeing, and physical function deteriorate among women with breast cancer. Tai
Chi is a moderate form of exercise that may be effective in improving the mental and physical wellbeing, therefore, the
quality of life of women with breast cancer. This protocol paper outlines a trial to determine the therapeutic effects of
a Tai Chi programme on breast cancer management.
Methods: The study will be an interventional, single-blind, double-armed, randomized, and controlled trial involving
a 12-week Tai Chi programme for women with breast cancer. Forty participants aged 18 years and above who are
diagnosed with breast cancer from the general community will be recruited. All participants will be randomized to
either a Tai Chi programme or a waiting list control group. The Tai Chi programme will involve 12 weeks of group
Tai Chi sessions, with 45 min per session, twice a week. The primary outcome will be potential improvements to the
quality of life, and secondary outcomes will be potential improvements in mental wellbeing (anxiety and depression), and
physical function (pain, flexibility, obesity, and vital signs). These outcomes will be assessed via self-administered online
assessments and physical examinations pre-and post-intervention. Linear mixed modelling will be used to assess changes
in outcomes.
Discussion and dissemination: Tai Chi is a safe, easy to learn, inexpensive, and low-intensity exercise with increasing
popularity worldwide. If the intervention improves the quality of life in women with breast cancer, this study will build
research capacity and increase awareness of the potential for Tai Chi to empower patients and engage them in selfmanagement of breast cancer symptoms. Research findings will be disseminated to the public, health professionals,
researchers, and healthcare providers through conference presentations, lay summaries, and peer-reviewed publications.
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Introduction
Globally, breast cancer (BC) is the most diagnosed cancer
and the leading cause of cancer mortality. It represents a
significant health challenge in all resource settings and
unmet health needs, with an estimated 2.3 million cases
recorded in 2020.1 By 2030, the global estimated number
of diagnosed cases and resulting deaths from BC will reach
26.4 million and 1.7 million, respectively.2 Approximately
55 Australians are diagnosed with BC each day, which
equates to over 20,000 Australians in 2021.3 Owing to the
advancements made through research, the 5-year survival
rate for women diagnosed with BC is 91.5%.4 With longer
survival rates, however, symptoms such as fatigue, insomnia, and depression often co-occur in BC patients and can
significantly affect functional status and quality of life
(QoL).5–7 These symptoms cannot usually be managed satisfactorily by pharmacological treatments alone.8 Thus,
non-pharmacological adjuvant approaches are recommended,9 and community-engaged, sustained, and accessible initiatives to improve the QoL, physical function, and
mental wellbeing of women with BC are urgently required.
There is strong evidence for body–mind meditative exercise to manage cancer-related symptoms. Recent studies
have identified that regular Tai Chi practice may help symptom management in cancer patients.10,11 Tai Chi, a moving
meditation, is a moderate body–mind exercise that integrates breathing into body movement. The central mechanism of Tai Chi emphasizes the unity of mind and body and
the coordination of breathing and body movement.12 This
proposed study will, therefore, examine the effectiveness of
a 12-week Tai Chi programme as a promising additional
approach to help promote QoL, mental wellbeing, and physical function of women with BC. The proposed programme
will be the first community-engaged, nurse-led Tai Chi programme specifically targeting BC patients.

Methods
Study design
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(t (144) = 5.761, p < 0.001) in the total QoL (mental and
physical aspects) between the control (−0.13 ± 10.92 preto-post difference) and intervention group (+8.86 ± 11.13
pre-to-post difference), from the data collected in their
study, which corresponded to a large effect (Cohen’s
d = 0.91). Within the QoL metric, emotional wellbeing
component saw the smallest change but still achieved a
medium effect (Cohen’s d = 0.58). With this statistic in
mind, we estimated the sample size using G*Power Version
3.1.10,16 based on a mixed model design (two groups and
two time-points) to detect at least a medium Group × Time
interaction effect (Cohen’s f = 0.25) for QoL (therapeutic
effect) at an α of 0.05 (two-tailed) and an 80% power and
5% level of significance. Therefore, the calculated required
sample size for this study is 34 participants. Considering a
potential drop-out rate of 15%, the adjusted required sample size has been adjusted to 40.

Randomization and blinding
Each participant will be assigned a computer-generated
sequence number using a randomized block approach. To
safeguard concealment, the block sizes will not be disclosed, and the allocation will be conducted blindly by an
independent statistician. The randomization list will be
controlled by the researcher who performed the intervention. Participants will be randomly assigned to one of the
two groups: (1) intervention group, who will be enrolled in
a 12-week Tai Chi programme (45 min per session, twice a
week one the same days each week) led by a qualified Tai
Chi practitioner. The programme combines mild to moderate physical intensity exercise with deep breathing and
meditation. It is a mixture of different Tai Chi styles (e.g.
Chen, Yang, Wu, and Kung Fu) combining meditation and
martial arts; or (2) waiting list control group, who will
receive usual care consisting of other types of moderate
exercise (e.g. walking) or medication. Outcome assessors
and team members who perform data entry and data analysis will be blinded to the randomization.

This study will be an interventional, single-blind, doublearmed, randomized, and controlled trial on the therapeutic
effect of a 12-week Tai Chi programme for women with
BC. While this trial protocol will be reported adhering to
the Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) reporting template, the trial
report will be guided by the principles of the CONsolidated
Standards of Reporting Trials (CONSORT) reporting template for clinical trials.13

Setting

Sample size estimation

Participants will be recruited from the community by the
research team via mass mailings, social media advertising,
flyers, and ‘snowball’ subject recruitment, which includes
word of mouth referrals. After expressing an interest in
participating in this trial, each potential participant will be

Calculation of a sample size is centred on the desired effect
size, level of significance, power, and expected attrition
rate.14 Oh and colleagues15 reported a significant difference

This proposed study will be conducted in Western
Australia, where BC is the most diagnosed cancer. The Tai
Chi programme is an ongoing community programme led
by nurses at multiple locations in the Perth metropolitan
area.

Study population and recruitment
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contacted and screened for inclusion by the investigators.
Inclusion criteria consist of adults (1) aged 18 years and
above, (2) diagnosed with BC, (3) having no physical or
cognitive limitations prohibiting exercise, and (4) willing
and able to commit to the 12-week trial. BC patients who
have had recent (< 3 months) experience in Tai Chi or are
experienced Tai Chi practitioners will be excluded from
the trial.

Public involvement
A consumer representative with lived experience of BC
will be involved in this study by providing input on study
design, how best to connect with potential study participants, and interpreting findings and dissemination of
research outcomes. Consumer involvement in this project
can help consider the implications of the research and how
it will lead to practical benefits for women with BC in the
future.17

Concomitant care
The 12-week Tai Chi programme is an ongoing initiative.
Participants can continue to attend Tai Chi classes at no
charge after completion of the study. Tai Chi is a safe, low
intensity, and enjoyable exercise, there is no anticipation
of any adverse events (physical or psychological) that will
occur during the sessions. Participants can stop at any time
if they experience discomfort.

Study procedure
All participants (intervention and control groups) will
complete self-reporting questionnaires at the start of the
programme (T0) and at its end (week 12; T1). Physical
assessments of all participants will also be conducted at T0
and T1. Figure 1 summarizes the schedule of enrolment,
interventions, and assessments.

Outcome measures
Primary and secondary outcomes. The primary outcome will
be QoL as measured by mean scores on the 12-item shortform health survey (SF-12)18,19 and the Euro QoL (EQ5D).20 This outcome will be obtained via two online
surveys from all participants: at baseline (T0) and postintervention (T1).
Secondary outcomes include anxiety as measured by
mean score on generalized anxiety disorder survey
(GAD-7);21 depression as measured by mean score on the
patient health questionnaire (PHQ-9);22 pain (if any) as
measured by mean scores on the visual analogue
scale (VAS)23,24 and the McGill pain questionnaire
(MPQ).25–28 These outcomes will be measured via two
online surveys (T0 and T1). Questions on participants’
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non-pharmacologic therapy preferences and experiences
of participating in the trial will also be captured and
measured at T0 and T1, respectively.
In addition to these self-reported online questionnaires,
physical assessments will also be conducted by the
research team at the research clinic site. These assessments
include flexibility as measured by finger to floor distance
(FFD); obesity as measured by mean scores on body mass
index (BMI); vital signs (blood pressure, heart rate, respiratory rate, temperate, and oxygen saturation) as measured by a blood pressure monitor, tympanic, and pulse
oximetry device. These outcomes will be measured at T0
and T1.
QoL assessment
SF-12. The SF-12 is a self-reported outcome measure
across eight domains (physical, social, usual role due to
physical issues, bodily pain, mental health, usual role due
to emotional issues, vitality, and health perceptions) that
assesses the impact of health on an individual’s QoL.18,19
The SF-12 is a validated tool,29–31 and scores on these
eight domains are aggregated to form two final components: physical and mental wellbeing scores. An algorithm
is used to generate the two components for comparison to
normative data: the mean score is set to 50, scores > 50
indicate better physical or mental health than the mean,
whereas scores < 50 indicate worse physical or mental
health than the mean.18,19
EQ-5D. The EQ-5D is the most commonly used healthrelated QoL questionnaire in adults.20 It consists of five
questions that assess functions in five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) with three possible levels of disability (3,
severe; 2, moderate; 1, none). EQ-5D is commonly used to
make evidence-based decisions in analyses of cost-effectiveness. Therefore, the EQ-5D can be used for health outcomes studies and economic analyses. Extensive research
has shown EQ-5D to be valid, reliable, and responsive.32,33
Anxiety assessment
GAD-7. The GAD-7 is a gold-standard measurement
tool for generalized anxiety disorder.21 It is a quick, userfriendly, concise, and self-administered screening and
diagnostic tool. GAD-7 is calculated by assigning scores
of 0, 1, 2, and 3 to the response categories of ‘not at all’,
‘several days’, ‘more than half the days’, and ‘nearly
every day’, respectively. GAD-7 total score, the sum of the
response scores for the seven items, ranges from 0 to 21.
Scores of 5, 10, and 15 represent cut-off points for mild,
moderate, and severe anxiety, respectively.
Depression assessment
PHQ-9. The PHQ-9 is a self-administered diagnostic
instrument for depression severity.22 It is calculated by
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Time point

Enrolment

Baseline
(T0)
Randomisation

Week -1

Week 0

Enrolment:

Randomisation

Informed consent

Post-allocation
12 weeks trial period
Week 1—Week 12

Close-out
(T1)
Post-trial,
week 13

X
X

Intervention:
12-week Tai Chi program + usual
care

X

X

Control:
Waiting list (usual care, e.g., other
exercise)

X

X

Assessments: All participants (Intervention & Control groups)
Quality of life
SF-12

X

X

EQ-5D

X

X

Anxiety assessment
GAD-7

X

X

Depression assessment
PHQ-9

X

X

Pain assessment
VAS

X

X

SF-MPQ

X

X

Flexibility
FFD

X

X

Obesity
BMI

X

X

Vital signs
BP, RR, HR, Temp., O2SAT

X

X

Non-pharmacologic therapy preference
Past 3-month choice of non-pharmacologic therapy

X
Participant’s experience (Intervention group only)

Participants’ experiences of the
intervention
Figure 1. Schedule of enrolment, interventions, and assessments.

X

BP: blood pressure; RR: respiratory rate; HT: heart rate; Temp.: temperature; O2SAT: oxygen saturation;; BMI: body mass index; EQ-5D: EuroQoL
(EQ-5D); FFD: finger to floor distance; GAD-7: generalized anxiety disorder 7; PHQ-9: patient health questionnaire; SF-12: 12-item short form
health survey; SF-MPQ: short-form McGill pain questionnaire; VAS: visual analogue scale.

Wang et al.
assigning scores of 0, 1, 2, and 3 to the response categories
of ‘not at all’, ‘several days’, ‘more than half the days’,
and ‘nearly every day’, respectively. PHQ-9 total score for
the nine items ranges from 0 to 27. Scores of 5, 10, 15, and
20 represent cut-off points for mild, moderate, moderately
severe, and severe depression.
Pain assessments
VAS and SF-MPQ. The VAS and the SF-MPQ are commonly used clinically to assess pain.34 VAS is a reliable,
validated tool with adequate sensitivity23,24 that is often
used to assess pain intensity. The MPQ is the most wellknown and popular multi-dimensional pain assessment
tool. The SF-MPQ consists of 15 pain descriptors: 11 that
assess the sensory dimension of pain and 4 that assess the
affective dimension of pain. Descriptors are rated on an
intensity scale of none (= 0), mild (= 1), moderate (= 2), and
severe (= 3). Three pain scores are derived from the sum of
the intensity rank values of the chosen sensory, affective,
and total descriptors.34 This questionnaire is used to measure the quality (i.e. using words to describe the pain, such
as ‘sharp’, ‘dull’, ‘stabbing’, ‘burning’, ‘crushing’, ‘throbbing’, ‘nauseating’, ‘shooting’, ‘twisting’, or ‘stretching’)
as well as the intensity of the pain.25–28
Flexibility. The FFD will be measured with the patient
bending forward maximally with knees straight. We will
use a ruler to assess flexibility by measuring the FFD. Two
measurements will be made and averaged.
Obesity. The BMI is an internationally recognized standard for classifying overweight and obesity in adults. BMI
is calculated by dividing a person’s weight in kilograms by
the square of their height in metres. A BMI of 25.0–29.9 is
classified as overweight but not obese, a BMI of 30.0 or
over is classified as obese, while a BMI of greater than
35.0 is classified as severely obese.35
Vital signs. Vital signs indicate the status of the body’s vital
functions. These measurements are taken to assess the
general physical health: body temperature (Temp), heart
rate (HR), respiratory rate (RR), blood pressure (BP), and
oxygen saturation (SpO2).36
Body temperature. Temperature is how hot or cold a person is, and a normal range is between 36.6 to 37.5 degrees
Celsius. Temperature is measured via a tympanic device.
Heart rate. HR is the number of heart beats per minute.
The normal range is between 60 to 100 beats per minute.
This result can be influenced by fitness level, age, illness,
and emotion.
Respiratory rate. RR is the number of breaths a person
takes per minute. It is measured through watching the rise
and fall of the chest and counting breaths for a full minute.
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The normal limit for an adult RR is between 12 and 20
breaths per min. A person’s RR is influenced by factors
such as resting or moving.
Blood pressure. BP consists of systolic pressure (the first
number) indicates the pressure of blood within the arteries
during a contraction of the left ventricle of the heart. The
diastolic reading (the second number) indicates the pressure within the arteries when the heart is at rest. According
to the Heart Foundation of Australia, as a general guide,
BP can be classified as ‘optimal’ (<120/80), ‘normal’
(120/80–129/84), and ‘high-normal’ (130/85–139/89).
High BP is further classified as mild (140–159/ 90–99),
moderate (160–179/100–109), or severe (⩾180/110).
Oxygen saturation. SpO2 estimates the level of oxygen
blood carries. A pulse oximetry device is used to present the
measurement with a percentage. If the red blood cells contain 95% oxygenated haemoglobin, the SpO2 would be 95%.
Normal pulse oximeter readings usually range from 95% to
100%. Values under 90% are considered low and indicate
the need for supplemental oxygen. This condition is often
referred to as hypoxemia, and its symptoms include severe
shortness of breath, increased heart rate, and chest pain.

Data analysis
Descriptive statistics for continuous variables will be
described by the mean and standard deviation (SD) for
normal data and by the median and interquartile range
(IQR) for non-normal data. Categorical data will be summarized by frequencies and proportions. Linear mixed
modelling with an unstructured covariance matrix will be
conducted to assess changes in outcomes throughout the
study. This modelling approach allows for the inclusion of
missing data in an intention-to-treat analysis without
imputations. Post hoc tests will be conducted on all pairwise comparisons. The analysis will be adjusted for potential confounding factors such as age, gender, education
levels, and any other potentially relevant variables where
data are available. The corrected Akaike Information
Criterion (AICc) will be used to assess model fit when
covariates are added to the model. Normality assumptions
will be assessed using the Shapiro–Wilk test. If required,
non-linear transformations such as the square root and logtransformations will be applied to normalize the data.
Statistical significance will be set at an alpha level of 0.05.
Effect sizes, defined by partial eta squared, will be reported
and interpreted, with 0.01, 0.06, and 0.014, respectively,
identified as small, medium, and large effects.37 All analyses will be conducted using R version 4.1.
The qualitative data collected via open-ended questions
from the post-intervention online survey will be used to
help explain or elaborate the quantitative data. Qualitative
data will be analysed using thematic analysis. Thematic
analysis uses ‘a prior’ code frame to analyse and report on
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the data.38 The analyses will be conducted using NVivo
version 12.

Discussion
Evidence has shown that Tai Chi can improve both physical and mental status of people with chronic diseases.39 It
is a safe, easy to learn, inexpensive, and moderate-intensity exercise with increasing popularity worldwide.40 The
results from this study will provide updated knowledge on
treatment options with the potential for women with BC to
self-manage to improve their QoL. Our recommendations
will inform healthcare policy and priorities in this area.
The results will provide insight into the potential alternative management strategies to support the improvement of
QoL, decision-making, and ultimately help women with
BC to enhance their QoL.
If the intervention improves the QoL of women with
BC, this study will build research capacity and increase
awareness of the potential for Tai Chi to empower patients
and engage them in self-management of BC symptoms to
improve the QoL.
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